Evolus News

Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating

Moomoo NewsNov 8 08:40 ET

A Quick Look at Today's Ratings for Evolus(EOLS.US), With a Forecast Between $20 to $27

Moomoo NewsNov 8 08:13 ET

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Poseida Therapeutics (PSTX) and Evolus (EOLS)

TipRanksNov 8 07:32 ET

Needham Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsNov 7 07:35 ET

Evolus Maintains Strong Growth Outlook Despite Earnings Miss: A Buy Recommendation

TipRanksNov 7 06:38 ET

H.C. Wainwright Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $27

Moomoo NewsNov 7 06:31 ET

Evolus Analyst Ratings

BenzingaNov 7 06:29 ET

Barclays Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsNov 7 03:34 ET

Barclays Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsNov 6 03:33 ET

Evolus Analyst Ratings

BenzingaNov 1 06:46 ET

H.C. Wainwright Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $27

Moomoo NewsNov 1 06:36 ET

Evolus Analyst Ratings

BenzingaOct 3 07:18 ET

H.C. Wainwright Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $27

Moomoo NewsOct 3 06:31 ET

Evolus Is Maintained at Overweight by Barclays

Dow JonesSep 13 12:09 ET

Stifel Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $25

Moomoo NewsSep 13 09:32 ET

Needham Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsSep 13 06:31 ET

Evolus Price Target Maintained With a $22.00/Share by Needham

Dow JonesSep 13 06:02 ET

Evolus Buy Rating Justified by Strong Market Positioning and Growth Projections

TipRanksSep 13 05:47 ET

Barclays Maintains Evolus(EOLS.US) With Buy Rating, Raises Target Price to $20

Moomoo NewsSep 13 03:32 ET

Mizuho Securities Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $23

Moomoo NewsSep 10 05:32 ET